These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19130750)

  • 1. Seroprevalence of HSV-2 in Hungary and comparison of the HSV-2 prevalence of pregnant and infertile women.
    Hettmann A; Gerle B; Barcsay E; Csiszár C; Takács M
    Acta Microbiol Immunol Hung; 2008 Dec; 55(4):429-36. PubMed ID: 19130750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel.
    Dan M; Sadan O; Glezerman M; Raveh D; Samra Z
    Sex Transm Dis; 2003 Nov; 30(11):835-8. PubMed ID: 14603091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HSV-1 and HSV-2 seropositivity rates in pregnant women admitted to Izmir Ataturk Research and Training Hospital, Turkey].
    Ozdemir R; Er H; Baran N; Vural A; Demirci M
    Mikrobiyol Bul; 2009 Oct; 43(4):709-11. PubMed ID: 20084927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of two ELISA tests to study the seroprevalence of herpes simplex 1 et 2 infection in a maternity near Paris].
    Benharrosh J; Dauphin H; Porcheret H; Meritet JF; Boulanger MC; Maisonneuve L
    Ann Biol Clin (Paris); 2008; 66(6):665-70. PubMed ID: 19091666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serological response to herpes simplex virus type 1 and 2 infection among women of reproductive age].
    Dordević H
    Med Pregl; 2006; 59(11-12):591-7. PubMed ID: 17633904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type 2 (HSV-2) infection in women attending an antenatal clinic in the South Pacific island nation of Vanuatu.
    Haddow LJ; Sullivan EA; Taylor J; Abel M; Cunningham AL; Tabrizi S; Mindel A
    Sex Transm Dis; 2007 May; 34(5):258-61. PubMed ID: 16940899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
    Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
    Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-infection of herpes simplex virus (HSV) with human immunodeficiency virus (HIV) in women with reproductive tract infections (RTI).
    Devi KM; Devi KhS; Singh NB; Singh NN; Singh ID
    J Commun Dis; 2008 Sep; 40(3):193-7. PubMed ID: 19245157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study.
    Kucera P; Gerber S; Marques-Vidal P; Meylan PR
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):13-7. PubMed ID: 21982938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalences of herpes simplex virus type 1 and type 2 among pregnant women in the Netherlands.
    Gaytant MA; Steegers EA; van Laere M; Semmekrot BA; Groen J; Weel JF; van der Meijden WI; Boer K; Galama JM
    Sex Transm Dis; 2002 Nov; 29(11):710-4. PubMed ID: 12438909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus infection in the Croatian population.
    Vilibic-Cavlek T; Kolaric B; Ljubin-Sternak S; Mlinaric-Galinovic G
    Scand J Infect Dis; 2011 Dec; 43(11-12):918-22. PubMed ID: 21696254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of Herpes simplex virus 2 infection among pregnant women in southern China.
    Li JM; Chen YR; Li XT; Xu WC
    J Dermatol; 2011 Feb; 38(2):120-4. PubMed ID: 21269306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low seroprevalence of herpes simplex virus type 2 among pregnant women in Senegal.
    Diawara S; Toure Kane C; Legoff J; Gaye AG; Mboup S; Bélec L
    Int J STD AIDS; 2008 Mar; 19(3):159-60. PubMed ID: 18397553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014.
    Marchi S; Trombetta CM; Gasparini R; Temperton N; Montomoli E
    J Prev Med Hyg; 2017 Mar; 58(1):E27-E33. PubMed ID: 28515628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seropositivity and determinants of immunoglobulin-G (IgG) antibodies against Herpes simplex virus (HSV) types -1 and -2 in pregnant women in Port Harcourt, Nigeria.
    Okonko IO; Cookey TI
    Afr Health Sci; 2015 Sep; 15(3):737-47. PubMed ID: 26957960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiology of herpes simplex type 2 in pregnant women in Belgium.
    Bodéus M; Laffineur K; Kabamba-Mukadi B; Hubinont C; Bernard P; Goubau P
    Sex Transm Dis; 2004 May; 31(5):297-300. PubMed ID: 15107632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of Herpes Simplex Virus type-2 (HSV-2) among pregnant women who participated in a national HIV surveillance activity in Haiti.
    Domercant JW; Jean Louis F; Hulland E; Griswold M; Andre-Alboth J; Ye T; Marston BJ
    BMC Infect Dis; 2017 Aug; 17(1):577. PubMed ID: 28821230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of HSV-1 and HSV-2 in Barbados.
    Levett PN
    Med Microbiol Immunol; 2005 Jan; 194(1-2):105-7. PubMed ID: 15156399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence study of herpes simplex virus type 2 among pregnant women in Germany using a type-specific enzyme immunoassay.
    Enders G; Risse B; Zauke M; Bolley I; Knotek F
    Eur J Clin Microbiol Infect Dis; 1998 Dec; 17(12):870-2. PubMed ID: 10052553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence and risk factors associated with herpes simplex virus infection among pregnant women.
    Arama V; Vladareanu R; Mihailescu R; Streinu Cercel A; Mihai C; Hristea A; Iosipenco M; Arama SS; Rabilloud M
    J Perinat Med; 2008; 36(3):206-12. PubMed ID: 18576929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.